Ferrell Andrew, Byrne T Karl, Robison Jacob G
Department of Surgery, Division of General Surgery, The Medical University of South Carolina, Charleston, SC, USA.
Obes Surg. 2004 Jun-Jul;14(6):738-43. doi: 10.1381/0960892041590962.
Surgical treatment of the morbidly obese has assumed an increasingly important role in both the academic and community setting, while postoperative pulmonary embolism remains a devastating complication. Since the overall incidence remains low, the role for vena cava filter placement in this group is not yet well defined. In addition, the technical challenges and techniques for insertion have not been well-described. We present our experience with filter placement among patients with gastric bypass and the evolution of technique to facilitate safe placement in this group.
From 1995 to August 2003, 586 patients underwent gastric bypass for morbid obesity. Review of registries and records from this period was accomplished to identify patients at MUSC who underwent both the gastric bypass and placement of an inferior vena cava filter. 12 patients were identified by this method.
Technical challenges with venous access and imaging are described. 6 patients were identified as potential high risk for thromboembolic complications and had a filter placed preoperatively with a mean postoperative stay of 5.3 days. The 6 patients who required filter placement in the postoperative period as part of the management of postoperative complications had a mean hospital stay of 24.5 days. There were no long-term complications associated with filter placement at a mean follow-up interval of 19 months.
Inferior vena cava filter placement is not only feasible and safe for the morbidly obese individual undergoing gastric bypass, but should be strongly considered for patients with risk factors for thromboembolic complications or who experience postoperative complications requiring ICU stay or prolonged immobility.
肥胖症的外科治疗在学术和临床环境中都发挥着越来越重要的作用,而术后肺栓塞仍然是一种极具破坏性的并发症。由于总体发病率仍然较低,下腔静脉滤器在该群体中的作用尚未明确界定。此外,滤器置入的技术挑战和操作方法也没有得到很好的描述。我们介绍了我们在胃旁路手术患者中进行滤器置入的经验以及为便于在该群体中安全置入而对技术的改进。
1995年至2003年8月,586例患者因病态肥胖接受了胃旁路手术。通过回顾这一时期的登记资料和记录,确定在南卡罗来纳医科大学同时接受胃旁路手术和下腔静脉滤器置入的患者。通过这种方法确定了12例患者。
描述了静脉通路和成像方面的技术挑战。6例患者被确定为血栓栓塞并发症的潜在高危患者,术前置入了滤器,术后平均住院时间为5.3天。作为术后并发症处理的一部分,在术后需要置入滤器的6例患者平均住院时间为24.5天。在平均19个月的随访期内,滤器置入未出现长期并发症。
对于接受胃旁路手术的病态肥胖个体,下腔静脉滤器置入不仅可行且安全,对于有血栓栓塞并发症危险因素或经历需要入住重症监护病房或长期制动的术后并发症的患者,应强烈考虑置入滤器。